中国实用妇科与产科杂志

中国实用妇科与产科杂志

• 专题笔谈 • 上一篇    下一篇

围产期心肌病诊治

  

  1. 华中科技大学同济医学院附属同济医院妇产科，湖北 武汉 430030
  • 出版日期:2019-11-02 发布日期:2019-11-15
  • 通讯作者: 冯玲
  • 基金资助:

    “生殖健康及重大出生缺陷防控研究”国家重点研发计划（2018YFC1002900）

Diagnosis and treatment of peripartum cardiomyopathy.

  1. Department of Obstetrics and Gynecology，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology，Wuhan 430030，China
  • Online:2019-11-02 Published:2019-11-15

摘要：

围产期心肌病（PPCM）典型症状以心力衰竭、呼吸困难为主要表现，超声心动图是首选检查。溴隐亭及口服抗心力衰竭药物是治疗主要手段，对于血流动力学不稳定的心力衰竭孕妇，无论孕周大小均应终止妊娠。孕产妇病死率的预测指标为纽约心脏病协会（NYHA）Ⅲ/Ⅳ分级和左心室射血分数（LVEF）＜40%。

关键词: 围产期心肌病, 溴隐亭, 心力衰竭, 左心室射血分数, 预测

Abstract:

Typical symptoms of peripartum cardiomyopathy（PPCM）are heart failure and dyspnea.Echocardiography is the first choice.Bromocriptine and oral drugs for heart failure are the main treatments.For pregnant women with heart failure with hemodynamic instability，pregnancy should be terminated regardless of the size of the gestational age.The predictors of maternal mortality are NYHA class Ⅲ/Ⅳ and left ventricular ejection fraction（LVEF）＜40%.

Key words: peripartum cardiomyopathy, bromocriptine, heart failure, left ventricular ejection fraction, prediction

中图分类号: